Zimmer proposes to mollify European anti-trust regulators on its pending, $13 billion acquisition of rival Biomet by selling off some of its knee and elbow assets in Europe.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tKtfmE
Cap comentari:
Publica un comentari a l'entrada